SS Innovations International, Inc. (NASDAQ: SSII) has taken a strategic step to enhance its corporate communications by engaging IBN, a comprehensive communications platform. The partnership aims to increase visibility among investors, journalists, and the broader market as the company continues to advance its portfolio of surgical robotic technologies.
SS Innovations' product lineup is led by its proprietary SSi Mantra surgical robotic system, which has been used in more than 11,700 procedures worldwide. The system is complemented by the SSi Mudra robotic instruments, SSi MantrAsana tele-surgeon console, and SSi Maya mixed-reality platform. This integrated suite of technologies underscores the company's commitment to making robotic surgery more affordable and accessible globally.
Under the agreement, IBN will leverage its investor-focused communications network, including InvestorWire and more than 5,000 syndication outlets, newsletters, social media channels, and other distribution platforms. The goal is to increase awareness of SS Innovations among key stakeholders. This move comes as the company, headquartered in India but American-owned, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
The engagement with IBN is expected to provide SS Innovations with a broad reach and a seasoned team of contributing journalists and writers, as highlighted in the press release. IBN is part of the Dynamic Brand Portfolio that delivers access to a vast network of wire solutions, article and editorial syndication, enhanced press release distribution, and social media distribution to millions of followers.
For more details on the original announcement, visit https://nnw.fm/Jiyh0. The latest news and updates relating to SSII are also available in the company's newsroom at https://nnw.fm/SSII.
This partnership highlights SS Innovations' proactive approach to communicating its milestones and technological advancements. With the SSi Mantra system already deployed in thousands of procedures, the company is positioned to capitalize on the growing demand for surgical robotics. The collaboration with IBN is likely to accelerate awareness and support the company's expansion plans, potentially influencing investor perception and market adoption of its technologies.
As SS Innovations continues to innovate, the engagement with IBN serves as a catalyst to ensure that its achievements and future developments are effectively communicated to a wide audience. This strategic communications move is important for stakeholders tracking the company's progress in the competitive surgical robotics landscape.
